In fact, the price of such vouchers has been climbing steadily in recent months, according to public disclosures surrounding ...
In a fit of boundless national optimism, Peugeot and Renault (and a few years later Volvo) teamed up to make a new V8 for good power and performance. But that's not what the world got. We welcomed in ...
Pharmaceutical Technology on MSN
JPM26: Jazz sells PRV for $200m, targets deals in 2026
The sale price marks an inflection in voucher market value over recent years.
While the price of just about everything has increased over the last six years in the U.S., the same can’t be said for the cost of an FDA priority review voucher. Just ask Sarepta Therapeutics. Since ...
The Priority Review Voucher (PRV) program is designed to incentivize rare disease drug development.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But as ...
TALLAHASSEE, FL / ACCESSWIRE / February 5, 2021 / Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results